{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:48:56Z","timestamp":1791676136042,"version":"4.3.4"},"reference-count":153,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12869-6","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T21:26:21Z","timestamp":1791667581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Flavonoids in treatment of tuberculosis: from molecular mechanisms to structure activity relationships"],"prefix":"10.1007","volume":"53","author":[{"given":"Ankita","family":"Bansal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diksha","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,10]]},"reference":[{"issue":"2","key":"12869_CR1","first-page":"2168","volume":"19","author":"T Kaur","year":"2019","unstructured":"Kaur T, Sharma P, Gupta G, Ntie-Kang F, Kumar D (2019) Treatment of tuberculosis by natural drugs: A review. Plant Arch 19(2):2168\u20132176","journal-title":"Plant Arch"},{"issue":"4","key":"12869_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0017601","volume":"6","author":"EW Tiemersma","year":"2011","unstructured":"Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJD (2011) Natural history of tuberculosis: Duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: A systematic review. PLoS ONE 6(4):1\u201313 https:\/\/www.who.int\/teams\/global-programme-on-tuberculosis-and-lung-health\/tb-reports\/global-tuberculosis-report-2025","journal-title":"PLoS ONE"},{"key":"12869_CR4","doi-asserted-by":"crossref","unstructured":"Goletti D, Meintjes G, Andrade BB, Zumla A, Lee SS (2025) Insights from the 2024 WHO global tuberculosis report\u2013more comprehensive action, innovation, and investments required for achieving WHO end TB goals. International Journal of Infectious Diseases, 150","DOI":"10.1016\/j.ijid.2024.107325"},{"issue":"3","key":"12869_CR5","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/resp.14887","volume":"30","author":"S Janssen","year":"2025","unstructured":"Janssen S, Murphy M, Upton C, Allwood B, Diacon AH (2025) Tuberculosis: an update for the clinician. Respirology 30(3):196\u2013205","journal-title":"Respirology"},{"issue":"1","key":"12869_CR6","doi-asserted-by":"publisher","first-page":"e061836","DOI":"10.1136\/bmjopen-2022-061836","volume":"13","author":"F Admassu","year":"2023","unstructured":"Admassu F, Abera E, Gizachew A, Sedoro T, Gari T (2023) Risk factors of multidrug resistant tuberculosis among patients with tuberculosis at selected multidrug resistance treatment initiative centres in southern Ethiopia: a case-control study. BMJ Open 13(1):e061836","journal-title":"BMJ Open"},{"issue":"58","key":"12869_CR7","doi-asserted-by":"publisher","first-page":"36459","DOI":"10.1039\/D1RA06238G","volume":"11","author":"RH Abd El-Aleam","year":"2021","unstructured":"Abd El-Aleam RH, George RF, Georgey HH, Abdel-Rahman HM (2021) Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance. RSC Adv 11(58):36459\u201336482","journal-title":"RSC Adv"},{"issue":"7","key":"12869_CR8","doi-asserted-by":"publisher","first-page":"e183","DOI":"10.1016\/S1473-3099(18)30110-5","volume":"18","author":"S Tiberi","year":"2018","unstructured":"Tiberi S, Du Plessis N, Walzl G, Vjecha MJ, Rao M, Ntoumi F, Mfinanga S, Kapata N, Mwaba P, McHugh TD, Ippolito G, Migliori GB, Maeurer MJ, Zumla A (2018) Tuberculosis: progress and advances in development of new drugs, treatment regimens, and host-directed therapies. Lancet Infect Dis 18(7):e183\u2013e198","journal-title":"Lancet Infect Dis"},{"key":"12869_CR9","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1093\/infdis\/jiu625","volume":"211","author":"RD Turner","year":"2015","unstructured":"Turner RD, Bothamley GH (2015) Cough and the transmission of tuberculosis. J Infect Dis 211:1367\u20131372","journal-title":"J Infect Dis"},{"key":"12869_CR10","doi-asserted-by":"publisher","first-page":"98","DOI":"10.3389\/fimmu.2013.00098","volume":"4","author":"E Guirado","year":"2013","unstructured":"Guirado E, Schlesinger LS (2013) Modeling the Mycobacterium tuberculosis granuloma \u2013 the critical battlefield in host immunity and disease. Front Immunol 4:98","journal-title":"Front Immunol"},{"key":"12869_CR11","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.smim.2014.09.009","volume":"26","author":"IM Orme","year":"2014","unstructured":"Orme IM, Basaraba RJ (2014) The formation of the granuloma in tuberculosis infection. Semin Immunol 26:601\u2013609","journal-title":"Semin Immunol"},{"issue":"suppl6","key":"12869_CR12","doi-asserted-by":"publisher","first-page":"S629","DOI":"10.1093\/infdis\/jix362","volume":"216","author":"G Churchyard","year":"2017","unstructured":"Churchyard G, Kim P, Shah NS, Rustomjee R, Gandhi N, Mathema B, Dowdy D, Kasmar A, Cardenas V (2017) What we know about tuberculosis transmission: an overview. J Infect Dis 216(suppl6):S629\u2013S635","journal-title":"J Infect Dis"},{"key":"12869_CR13","doi-asserted-by":"crossref","unstructured":"Getachew S, Medhin G, Asres A, Abebe G, Ameni G (2022) Traditional medicinal plants used in the treatment of tuberculosis in Ethiopia: A systematic review. Heliyon 1\u201310","DOI":"10.1016\/j.heliyon.2022.e09478"},{"issue":"2","key":"12869_CR14","doi-asserted-by":"publisher","first-page":"396","DOI":"10.22271\/phyto.2025.v14.i2e.15315","volume":"14","author":"M Parmar","year":"2025","unstructured":"Parmar M, Tripathi S, Bhavsar K, Baraiya J, Vegada R (2025) Tuberculosis and herbal plants: Exploring new horizons in treatment. J Pharmacognosy Phytochemistry 14(2):396\u2013407","journal-title":"J Pharmacognosy Phytochemistry"},{"issue":"16","key":"12869_CR15","doi-asserted-by":"publisher","first-page":"8649","DOI":"10.3390\/ijms22168649","volume":"22","author":"L Koklesova","year":"2021","unstructured":"Koklesova L, Liskova A, Samec M, Zhai K, Al-Ishaq RK, Bugos O, \u0160udomov\u00e1 M, Biringer K, Pec M, Adamkov M, Hassan STS, Saso L, Giordano FA, B\u00fcsselberg D, Kubatka P, Golubnitschaja O (2021) Protective effects of flavonoids against mitochondriopathies and associated pathologies: Focus on the predictive approach and personalized prevention. Int J Mol Sci 22(16):8649","journal-title":"Int J Mol Sci"},{"key":"12869_CR16","doi-asserted-by":"crossref","unstructured":"Singh VK, Mishra A, Jagannath C, Khan A (2022) Emerging natural product based alternative therapeutics for tuberculosis. In: Sarwat M, Siddique H (ed) Herbal Medicines. Academic., pp 453\u201347","DOI":"10.1016\/B978-0-323-90572-5.00017-2"},{"key":"12869_CR17","doi-asserted-by":"publisher","first-page":"122400","DOI":"10.1016\/j.indcrop.2025.122400","volume":"239","author":"J Liu","year":"2026","unstructured":"Liu J, Chen X, Li S, Fang K, Sheng Y, Wang X, Wang Y, Zhang J, Wang D (2026) Exploring the antimicrobial mechanisms of flavonoids with phenolic hydroxyl groups: Implications for novel wound dressings. Ind Crops Prod 239:122400","journal-title":"Ind Crops Prod"},{"key":"12869_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/B978-0-12-817905-5.00003-2","volume":"65","author":"PK Boniface","year":"2020","unstructured":"Boniface PK, Ferreira EI (2020) Opportunities and challenges for flavonoids as potential leads for the treatment of tuberculosis. Stud Nat Prod Chem 65:85\u2013124","journal-title":"Stud Nat Prod Chem"},{"issue":"5","key":"12869_CR19","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1039\/C4FO01178C","volume":"6","author":"K Kawabata","year":"2015","unstructured":"Kawabata K, Mukai R, Ishisaka A (2015) Quercetin and related polyphenols: new insights and implications for their bioactivity and bioavailability. Food Funct 6(5):1399\u20131417","journal-title":"Food Funct"},{"issue":"4","key":"12869_CR20","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1021\/acs.jnatprod.5b01033","volume":"79","author":"HN Jnawali","year":"2016","unstructured":"Jnawali HN, Jeon D, Jeong MC, Lee E, Jin B, Ryoo S, Yoo J, Jung ID, Lee SJ, Park YM, Kim Y (2016) Antituberculosis activity of a naturally occurring flavonoid, Isorhamnetin. J Nat Prod 79(4):961\u2013969","journal-title":"J Nat Prod"},{"issue":"2","key":"12869_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.2174\/1389557516666160505114603","volume":"17","author":"D Sharma","year":"2017","unstructured":"Sharma D, Parkash Yadav J (2017) An overview of phytotherapeutic approaches for the treatment of tuberculosis. Mini Rev Med Chem 17(2):167\u2013183","journal-title":"Mini Rev Med Chem"},{"key":"12869_CR22","doi-asserted-by":"crossref","unstructured":"Sharma V, Sharma D, Saini M, Jain A, Chaudhary J, Kaur N, Sahoo N, Singh SK, Goyal K, Rekha A, Ali H, Gupta S, Hussain MS, Gupta G (2025) Flavonoids as antimicrobial agents: a comprehensive review of mechanisms and therapeutic potential. Current Pharmaceutical Biotechnology","DOI":"10.2174\/0113892010384002250628163849"},{"issue":"5","key":"12869_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s13659-020-00257-x","volume":"10","author":"L Wang","year":"2020","unstructured":"Wang L, Song J, Liu A, Xiao B, Li S, Wen Z, Du G (2020) Research progress of the antiviral bioactivities of natural flavonoids. Nat Prod bioprospecting 10(5):271\u2013283","journal-title":"Nat Prod bioprospecting"},{"issue":"1","key":"12869_CR24","doi-asserted-by":"publisher","first-page":"28","DOI":"10.2174\/1573407215666191120125608","volume":"17","author":"R Kaur","year":"2021","unstructured":"Kaur R, Kaur K, Arora R, Saini B, Arora S (2021) Natural fused heterocyclic flavonoids: potent candidates as anti-inflammatory and anti-allergic agents in the treatment of asthma. Curr Bioact Compd 17(1):28\u201340","journal-title":"Curr Bioact Compd"},{"key":"12869_CR25","doi-asserted-by":"publisher","first-page":"1102225","DOI":"10.3389\/fnut.2023.1102225","volume":"10","author":"T Wu","year":"2023","unstructured":"Wu T, Li Z, Wu Y, Yang X, Li L, Chen S, Qi B, Wang Y, Li C, Zhao Y (2023) Exploring plant polyphenols as anti-allergic functional products to manage the growing incidence of food allergy. Front Nutr 10:1102225","journal-title":"Front Nutr"},{"issue":"23","key":"12869_CR26","doi-asserted-by":"publisher","first-page":"14835","DOI":"10.3390\/ijms232314835","volume":"23","author":"A Calderaro","year":"2022","unstructured":"Calderaro A, Patan\u00e8 GT, Tellone E, Barreca D, Ficarra S, Misiti F, Lagan\u00e0 G (2022) The neuroprotective potentiality of flavonoids on Alzheimer\u2019s disease. Int J Mol Sci 23(23):14835","journal-title":"Int J Mol Sci"},{"issue":"1","key":"12869_CR27","doi-asserted-by":"publisher","first-page":"4139117","DOI":"10.1155\/2023\/4139117","volume":"2023","author":"A Gajender, Mazumder","year":"2023","unstructured":"Gajender, Mazumder A, Sharma A, Azad MA (2023) A comprehensive review of the pharmacological importance of dietary flavonoids as hepatoprotective agents. Evidence-Based Complement Altern Med 2023(1):4139117","journal-title":"Evidence-Based Complement Altern Med"},{"issue":"1","key":"12869_CR28","first-page":"30","volume":"1","author":"S Saraf","year":"2007","unstructured":"Saraf S, Ashawat MS, Saraf S (2007) Flavonoids: A nutritional protection against oxidative and UV induced cellular damages. Pharmacogn Rev 1(1):30\u201340","journal-title":"Pharmacogn Rev"},{"issue":"13","key":"12869_CR29","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.3390\/molecules26134021","volume":"26","author":"J Khan","year":"2021","unstructured":"Khan J, Deb PK, Priya S, Medina KD, Devi R, Walode SG, Rudrapal M (2021) Dietary flavonoids: Cardioprotective potential with antioxidant effects and their pharmacokinetic, toxicological and therapeutic concerns. Molecules 26(13):4021","journal-title":"Molecules"},{"issue":"8","key":"12869_CR30","doi-asserted-by":"publisher","first-page":"836","DOI":"10.2174\/187152012802650075","volume":"12","author":"EJ Park","year":"2012","unstructured":"Park EJ, Pezzuto M, J (2012) Flavonoids in cancer prevention. Anti-Cancer Agents Med Chemistry-Anti-Cancer Agents) 12(8):836\u2013851","journal-title":"Anti-Cancer Agents Med Chemistry-Anti-Cancer Agents)"},{"key":"12869_CR31","unstructured":"Jim\u00e9nez-Moreno AM, Asuero AG (2017) Anthocyanin pigments: Importance, sample preparation and extraction. Phenolic Compounds: Nat Sources Importance. IntechOpen, London"},{"issue":"1","key":"12869_CR32","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3390\/nu15010092","volume":"15","author":"K Anbualakan","year":"2022","unstructured":"Anbualakan K, Tajul Urus NQ, Makpol S, Jamil A, Mohd Ramli ES, Pauzi M, S. H., Muhammad N (2022) A scoping review on the effects of carotenoids and flavonoids on skin damage due to ultraviolet radiation. Nutrients 15(1):92","journal-title":"Nutrients"},{"key":"12869_CR33","doi-asserted-by":"publisher","first-page":"107287","DOI":"10.1016\/j.micpath.2025.107287","volume":"200","author":"E Aydin","year":"2025","unstructured":"Aydin E, Gunduz MK, Kaymak G, Sezgin AK, Da\u011fgez H, Renders DP, Yakupo\u011fullari Y (2025) Antimycobacterial activity of luteolin in resistant Mycobacterium tuberculosis isolates and cytotoxicity on L929 cells. Microb Pathog 200:107287","journal-title":"Microb Pathog"},{"issue":"19","key":"12869_CR34","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.3390\/molecules27196714","volume":"27","author":"S Garg","year":"2022","unstructured":"Garg S, Kumar R, Kunimoto D, Rayat GR (2022) Anti-Mycobacterial activity of flavonoid and pyrimidine compounds. Molecules 27(19):6714","journal-title":"Molecules"},{"key":"12869_CR35","doi-asserted-by":"publisher","first-page":"1063453","DOI":"10.3389\/fphar.2022.1063453","volume":"13","author":"JWC Alffenaar","year":"2022","unstructured":"Alffenaar JWC, de Steenwinkel JE, Diacon AH, Simonsson US, Srivastava S, Wicha SG (2022) Pharmacokinetics and pharmacodynamics of anti-tuberculosis drugs: an evaluation of in vitro, in vivo methodologies and human studies. Front Pharmacol 13:1063453","journal-title":"Front Pharmacol"},{"key":"12869_CR36","doi-asserted-by":"publisher","first-page":"937","DOI":"10.14233\/ajchem.2022.23620","volume":"34","author":"VS Honmore","year":"2022","unstructured":"Honmore VS, Natu AD, Khedkar VM, Sarkar VD, Rojatkar SR (2022) Flavonoids from Alpinia Officinarum As Potential Anti-Tubercular Agents Using Molecular Docking Studies. ajc 34:937\u2013944","journal-title":"ajc"},{"issue":"80","key":"12869_CR37","first-page":"791","volume":"18","author":"KN Venugopala","year":"2022","unstructured":"Venugopala KN, Chaudhary J, Sharma V (2022) Exploring the potential of flavonoids as efflorescing antidiabetic: An updated SAR and mechanistic based approach. Pharmacognosy Magazine 18(80):791\u2013807","journal-title":"Pharmacognosy Magazine"},{"issue":"8","key":"12869_CR38","doi-asserted-by":"publisher","first-page":"3599","DOI":"10.3390\/molecules28083599","volume":"28","author":"WB Zhuang","year":"2023","unstructured":"Zhuang WB, Li YH, Shu XC, Pu YT, Wang XJ, Wang T, Wang Z (2023) The classification, molecular structure and biological biosynthesis of flavonoids, and their roles in biotic and abiotic stresses. Molecules 28(8):3599","journal-title":"Molecules"},{"key":"12869_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2020.00694","volume":"11","author":"M Sharifi-Rad","year":"2020","unstructured":"Sharifi-Rad M, Kumar NVA, Zucca P, Varoni EM, Dini L, Panzarini E, Rajkovic J, Tsouh PVF, Azzini E, Peluso I, Mishra AP, Nigam M, El Rayess Y, Beyrouthy ME, Polito L, Iriti M, Martins N, Martorell M, Docea AO, Setzer WN, Calina D, Cho WC, Sharifi-Rad J (2020) Lifestyle, oxidative stress, and antioxidants: Back and forth in the pathophysiology of chronic diseases. Front Physiol 11:1\u201321","journal-title":"Front Physiol"},{"key":"12869_CR40","doi-asserted-by":"publisher","first-page":"757","DOI":"10.2147\/CIA.S158513","volume":"13","author":"L Ilaria","year":"2018","unstructured":"Ilaria L, Gennaro R, Francesco C, Giulia B, Luisa A, Della-Morte D, Gargiulo G, Gianluca T, Cacciatore F, Bonaduce D, Abete P (2018) Clin Interv Aging 13:757\u2013772","journal-title":"Clin Interv Aging"},{"issue":"1","key":"12869_CR41","first-page":"5594386","volume":"2024","author":"SG Tumilaar","year":"2024","unstructured":"Tumilaar SG, Hardianto A, Dohi H, Kurnia D (2024) A comprehensive review of free radicals, oxidative stress, and antioxidants: Overview, clinical applications, global perspectives, future directions, and mechanisms of antioxidant activity of flavonoid compounds. J Chem 2024(1):5594386","journal-title":"J Chem"},{"key":"12869_CR42","first-page":"1","volume":"Longevity","author":"MD Shastri","year":"2018","unstructured":"Shastri MD, Shukla SD, Chong WC, Peterson DK, Patel GM, R. M., Philip M. H. R. F (2018) Role of oxidative stress in the pathology and management of human tuberculosis. Oxidative Med Cell Longevity:1\u201310","journal-title":"Oxidative Med Cell"},{"issue":"4","key":"12869_CR43","doi-asserted-by":"publisher","first-page":"937","DOI":"10.14233\/ajchem.2022.23620","volume":"34","author":"VS Honmore","year":"2022","unstructured":"Honmore VS, Natu AD, Khedkar V, Sarkar D, Rojatkar SR (2022) Flavonoids from Alpinia officinarum as PotentialAnti-Tubercular Agents Using Molecular Docking Studies. Asian J Chem 34(4):937\u2013944","journal-title":"Asian J Chem"},{"issue":"2","key":"12869_CR44","doi-asserted-by":"publisher","first-page":"33","DOI":"10.22206\/cac.2023.v6i2.3021","volume":"6","author":"B Rodr\u00edguez","year":"2023","unstructured":"Rodr\u00edguez B, Pacheco L, Bernal I, Pi\u00f1a M (2023) Mechanisms of action of flavonoids: antioxidant, antibacterial and antifungal properties. Ciencia Ambiente y Clima 6(2):33\u201366","journal-title":"Ciencia Ambiente y Clima"},{"key":"12869_CR45","first-page":"1","volume":"5","author":"JA Luke","year":"2015","unstructured":"Luke JA, Harrison J, Lloyd GS, Helen L, Birch HLB (2015) The mycobacterial cell wall\u2014peptidoglycan and arabinogalactan. Cold Spring Harbor Perspect Med 5:1\u201315","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"5","key":"12869_CR46","doi-asserted-by":"publisher","first-page":"660","DOI":"10.3390\/pharmaceutics13050660","volume":"13","author":"G Donadio","year":"2021","unstructured":"Donadio G, Mensitieri F, Santoro V, Parisi V, Bellone ML, De Tommasi N, Izzo V, Dal Piaz F (2021) Interactions with microbial proteins driving the antibacterial activity of flavonoids. Pharmaceutics 13(5):660","journal-title":"Pharmaceutics"},{"issue":"3","key":"12869_CR47","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ijmyco.2015.05.004","volume":"4","author":"JM Nguta","year":"2015","unstructured":"Nguta JM, Appiah-Opong R, Nyarko AK, Yeboah-Manu D, Addo PG (2015) Current perspectives in drug discovery against tuberculosis from natural products. Int J Mycobacteriology 4(3):165\u2013183","journal-title":"Int J Mycobacteriology"},{"key":"12869_CR48","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ijantimicag.2008.06.010","volume":"32","author":"D Wu","year":"2008","unstructured":"Wu D, Kong Y, Han C, Chen J, Hu L, Jiang H, Shen X (2008) D-Alanine: D-Alanine Ligase as a new target for the flavonoids quercetin and apigenin. Int J Antimicrob Agents 32:421\u2013426","journal-title":"Int J Antimicrob Agents"},{"issue":"949","key":"12869_CR49","first-page":"1","volume":"10","author":"A Pawar","year":"2020","unstructured":"Pawar A, Jha P, Chopra M, Chaudhry U, Saluja D (2020) Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids. Sci Rep 10(949):1\u201312","journal-title":"Sci Rep"},{"key":"12869_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-58967-8","volume":"10","author":"C Lefebvre","year":"2020","unstructured":"Lefebvre C, Frigui W, Slama N (2020) Discovery of a novel dehydratase of the fatty acid synthase type II critical for ketomycolic acid biosynthesis and virulence of Mycobacterium tuberculosis. Sci Rep 10:1\u201312","journal-title":"Sci Rep"},{"issue":"2","key":"12869_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.3390\/ph15020197","volume":"15","author":"DM Ahmed","year":"2022","unstructured":"Ahmed DM, Chen JM, Sanders DA (2022) Pyrazole and triazole derivatives as mycobacterium tuberculosis UDP-galactopyranose inhibitors. Pharmaceuticals 15(2):197","journal-title":"Pharmaceuticals"},{"key":"12869_CR52","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.carres.2015.10.008","volume":"419","author":"Y Mahdavi-Amiri","year":"2016","unstructured":"Mahdavi-Amiri Y, Mohan S, Borrelli S, Slowski K, Sanders DA, Pinto BM (2016) Mechanism-based candidate inhibitors of uridine diphosphate galactopyranose mutase (UGM). Carbohydr Res 419:1\u20137","journal-title":"Carbohydr Res"},{"key":"12869_CR53","doi-asserted-by":"publisher","first-page":"107787","DOI":"10.1016\/j.micpath.2025.107787","volume":"206","author":"SP Amingad","year":"2025","unstructured":"Amingad SP, Hakkimane SS (2025) Plant-based natural compounds as novel therapeutic avenues against tuberculosis: Emphasis on curcumin. Microb Pathog 206:107787","journal-title":"Microb Pathog"},{"key":"12869_CR54","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/j.ijantimicag.2016.04.007","volume":"47","author":"S Lele","year":"2016","unstructured":"Lele S, Xueqiong W (2016) Development of efflux pump inhibitors in antituberculosis therapy. Int J Antimicrob Agents 47:6: 421\u2013429","journal-title":"Int J Antimicrob Agents"},{"issue":"7","key":"12869_CR55","doi-asserted-by":"publisher","first-page":"390","DOI":"10.3390\/antibiotics9070390","volume":"9","author":"HT Tran","year":"2020","unstructured":"Tran HT, Solnier J, Pferschy-Wenzig EM, Kunert O, Martin L, Bhakta S, Huynh L, Le TM, Bauer R, Bucar F (2020) Antimicrobial and efflux pump inhibitory activity of carvotacetones from Sphaeranthus africanus against mycobacteria. Antibiotics 9(7):390","journal-title":"Antibiotics"},{"issue":"11","key":"12869_CR56","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1002\/cbdv.201000367","volume":"8","author":"TH Chou","year":"2011","unstructured":"Chou TH, Chen JJ, Peng CF, Cheng MJ, Chen IS (2011) New flavanones from the leaves of Cryptocarya chinensis and their antituberculosis activity. Chem Biodivers 8(11):2015\u20132024","journal-title":"Chem Biodivers"},{"key":"12869_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/molecules25030734","volume":"25","author":"J Solnier","year":"2020","unstructured":"Solnier J, Liam M, Sanjib B, Franz B (2020) Flavonoids as novel efflux pump inhibitors and antimicrobials against both environmental and pathogenic intracellular mycobacterial species. Molecules 25:1\u201312. https:\/\/doi.org\/10.3390\/molecules25030734","journal-title":"Molecules"},{"issue":"3","key":"12869_CR58","doi-asserted-by":"publisher","first-page":"734","DOI":"10.3390\/molecules25030734","volume":"25","author":"J Solnier","year":"2020","unstructured":"Solnier J, Martin L, Bhakta S, Bucar F (2020) Flavonoids as novel efflux pump inhibitors and antimicrobials against both environmental and pathogenic intracellular mycobacterial species. Molecules 25(3):734","journal-title":"Molecules"},{"issue":"9","key":"12869_CR59","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1586\/eri.12.89","volume":"10","author":"M Viveiros","year":"2012","unstructured":"Viveiros M, Martins M, Rodrigues L, Machado D, Couto I, Ainsa J, Amaral L (2012) Inhibitors of mycobacterial efflux pumps as potential boosters for anti-tubercular drugs. Expert Rev anti-infective therapy 10(9):983\u2013998","journal-title":"Expert Rev anti-infective therapy"},{"key":"12869_CR60","doi-asserted-by":"publisher","first-page":"2990","DOI":"10.3389\/fmicb.2018.02990","volume":"9","author":"V Shriram","year":"2018","unstructured":"Shriram V, Khare T, Bhagwat R, Shukla R, Kumar V (2018) Inhibiting bacterial drug efflux pumps via phyto-therapeutics to combat threatening antimicrobial resistance. Front Microbiol 9:2990","journal-title":"Front Microbiol"},{"issue":"9","key":"12869_CR61","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3390\/antibiotics10091075","volume":"10","author":"K \u0160imunovi\u0107","year":"2021","unstructured":"\u0160imunovi\u0107 K, Solnier J, Alperth F, Kunert O, Mo\u017eina SS, Bucar F (2021) Efflux pump inhibition and resistance modulation in Mycobacterium smegmatis by Peucedanum ostruthium and its coumarins. Antibiotics 10(9):1075","journal-title":"Antibiotics"},{"issue":"1","key":"12869_CR62","doi-asserted-by":"publisher","first-page":"989","DOI":"10.15212\/bioi-2025-0034","volume":"6","author":"G Kumar","year":"2025","unstructured":"Kumar G, Mondal P, Kadam A, Dhamija I, Singh RP, Nathiya D, Kumar SR (2025) Combating Multi- drug Resistant Mycobacterium Species by Efflux Pump Inhibitors: Contemporary Trends. BIO Integr 6(1):989","journal-title":"BIO Integr"},{"issue":"9","key":"12869_CR63","doi-asserted-by":"publisher","first-page":"4030","DOI":"10.3390\/ijms26094030","volume":"26","author":"A Duda-Madej","year":"2025","unstructured":"Duda-Madej A, Viscardi S, Niezg\u00f3dka P, Szewczyk W, Wi\u0144ska K (2025) The Impact of Plant-Derived Polyphenols on Combating Efflux-Mediated Antibiotic Resistance. Int J Mol Sci 26(9):4030","journal-title":"Int J Mol Sci"},{"issue":"2","key":"12869_CR64","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s13167-025-00407-6","volume":"16","author":"P Kubatka","year":"2025","unstructured":"Kubatka P, Bojkova B, Nosalova N, Huniadi M, Samuel SM, Sreenesh B, Harklova G, Kajo K, Hornak S, Cizkova D, Bubnov R, Smokovski I, Busselberg D, Golubnitschaja O (2025) Targeting the MAPK signaling pathway: implications and prospects of flavonoids in 3P medicine as modulators of cancer cell plasticity and therapeutic resistance in breast cancer patients. EPMA J 16(2):437\u2013463","journal-title":"EPMA J"},{"issue":"6","key":"12869_CR65","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1039\/C5FO00149H","volume":"6","author":"WC Huang","year":"2015","unstructured":"Huang WC, Wu SJ, Tu RS, Lai YR, Liou CJ (2015) Phloretin inhibits interleukin-1\u03b2-induced COX-2 and ICAM-1 expression through inhibition of MAPK, Akt, and NF-\u03baB signaling in human lung epithelial cells. Food Funct 6(6):1960\u20131967","journal-title":"Food Funct"},{"issue":"1","key":"12869_CR66","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/molecules22010183","volume":"22","author":"D Jeon","year":"2017","unstructured":"Jeon D, Jeong MC, Jnawali HN, Kwak C, Ryoo S, Jung ID, Kim Y (2017) Phloretin exerts anti-tuberculosis activity and suppresses lung inflammation. Molecules 22(1):183","journal-title":"Molecules"},{"key":"12869_CR67","doi-asserted-by":"crossref","unstructured":"Singh DK, Tousif S, Bhaskar A, Devi A, Negi K, Moitra B, Ranganathan A, Dwivedi VP, Das G (2021) Luteolin as a potential host-directed immunotherapy adjunct to isoniazid treatment of tuberculosis. PLoS Pathog 17(8):1009805","DOI":"10.1371\/journal.ppat.1009805"},{"key":"12869_CR68","doi-asserted-by":"crossref","unstructured":"Zhang X, Wang G, Gurley EC, Zhou H (2014) Flavonoid apigenin inhibits lipopolysaccharide-induced inflammatory response through multiple mechanisms in macrophages. PLoS ONE 9(9):107072","DOI":"10.1371\/journal.pone.0107072"},{"key":"12869_CR69","doi-asserted-by":"publisher","first-page":"1663992","DOI":"10.3389\/fcimb.2025.1663992","volume":"15","author":"Y Yao","year":"2025","unstructured":"Yao Y, Li K, Chai Y, Deng X, Li M, Lan J, Liang F, Wu X, Lei H (2025) Dysregulation of the JNK signaling pathway in tuberculosis: mechanisms and therapeutic strategies. Front Cell Infect Microbiol 15:1663992","journal-title":"Front Cell Infect Microbiol"},{"key":"12869_CR70","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tube.2017.11.005","volume":"108","author":"NA Safwat","year":"2018","unstructured":"Safwat NA, Kashef MT, Aziz RK, Amer KF, Ramadan MA (2018) Quercetin 3-O-glucoside recovered from the wild Egyptian Sahara plant, Euphorbia paralias L., inhibits glutamine synthetase and has antimycobacterial activity. Tuberculosis 108:106\u2013113","journal-title":"Tuberculosis"},{"issue":"1","key":"12869_CR71","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1039\/D1NP00011J","volume":"39","author":"J Han","year":"2022","unstructured":"Han J, Liu X, Zhang L, Quinn RJ, Feng Y (2022) Anti-mycobacterial natural products and mechanisms of action. Nat Prod Rep 39(1):77\u201389","journal-title":"Nat Prod Rep"},{"issue":"8","key":"12869_CR72","doi-asserted-by":"publisher","first-page":"450","DOI":"10.3390\/antibiotics9080450","volume":"9","author":"S Mickymaray","year":"2020","unstructured":"Mickymaray S, Alfaiz FA, Paramasivam A (2020) Efficacy and mechanisms of flavonoids against the emerging opportunistic nontuberculous Mycobacteria. Antibiotics 9(8):450","journal-title":"Antibiotics"},{"issue":"8","key":"12869_CR73","doi-asserted-by":"publisher","first-page":"101860","DOI":"10.1016\/j.jics.2025.101860","volume":"102","author":"A Ali","year":"2025","unstructured":"Ali A, Ali A, Khan A, Imran M (2025) Exploring natural inhibitors of Mycobacterium tuberculosis glutamine synthetase using molecular modeling, scaffold hopping, and machine learning-based bioactivity prediction. J Indian Chem Soc 102(8):101860","journal-title":"J Indian Chem Soc"},{"issue":"1","key":"12869_CR74","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41598-020-57658-8","volume":"10","author":"A Pawar","year":"2020","unstructured":"Pawar A, Jha P, Chopra M, Chaudhry U, Saluja D (2020) Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids. Sci Rep 10(1):949","journal-title":"Sci Rep"},{"issue":"1","key":"12869_CR75","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s10930-010-9302-0","volume":"30","author":"CC Chen","year":"2011","unstructured":"Chen CC, Huang CY (2011) Inhibition of Klebsiella pneumoniae DnaB helicase by the flavonol galangin. Protein J 30(1):59\u201365","journal-title":"Protein J"},{"key":"12869_CR76","doi-asserted-by":"publisher","first-page":"1524607","DOI":"10.3389\/fchem.2025.1524607","volume":"13","author":"T Elsaman","year":"2025","unstructured":"Elsaman T, Mohamed MA, Mohamed MS, Eltayib EM, Abdalla AE (2025) Microbial-based natural products as potential inhibitors targeting DNA gyrase B of Mycobacterium tuberculosis: An in silico study. Front Chem 13:1524607","journal-title":"Front Chem"},{"issue":"5","key":"12869_CR77","first-page":"8587","volume":"18","author":"B Suriyanarayanan","year":"2013","unstructured":"Suriyanarayanan B, Shanmugam K, Santhosh RS (2013) Synthetic quercetin inhibits mycobacterial growth possibly by interacting with DNA gyrase. Rom Biotechnol Lett 18(5):8587\u20138593","journal-title":"Rom Biotechnol Lett"},{"issue":"1","key":"12869_CR78","first-page":"735368","volume":"2012","author":"HH Lin","year":"2012","unstructured":"Lin HH, Huang CY (2012) Characterization of flavonol inhibition of DnaB helicase: Real-time monitoring, structural modeling, and proposed mechanism. Biomed Res Int 2012(1):735368","journal-title":"Biomed Res Int"},{"issue":"19","key":"12869_CR79","doi-asserted-by":"publisher","first-page":"6714","DOI":"10.3390\/molecules27196714","volume":"27","author":"S Garg","year":"2022","unstructured":"Garg S, Kumar R, Kunimoto D, Rayat GR (2022) Anti-Mycobacterial activity of flavonoid and pyrimidine compounds. Molecules 27(19):6714","journal-title":"Molecules"},{"key":"12869_CR80","doi-asserted-by":"crossref","unstructured":"Volynets G. Gudzera O. Lukashov S. Usenko M. et al (2025) Identification of Novel Dual-targeting Inhibitors of Aminoacyl-tRNA Synthetases in Mycobacterium tuberculosis. Current Enzyme Inhibition.","DOI":"10.2174\/0115734080401691251001061104"},{"issue":"5","key":"12869_CR81","doi-asserted-by":"publisher","first-page":"851","DOI":"10.3390\/molecules24050851","volume":"24","author":"R Cao","year":"2019","unstructured":"Cao R, Teskey G, Islamoglu H, Gutierrez M, Salaiz O, Munjal S, Fraix MP, Sathananthan A, Nieman DC, Venketaraman V (2019) Flavonoid mixture inhibits Mycobacterium tuberculosis survival and infectivity. Molecules 24(5):851","journal-title":"Molecules"},{"issue":"3","key":"12869_CR82","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.drudis.2016.11.006","volume":"22","author":"V Nagaraja","year":"2017","unstructured":"Nagaraja V, Godbole AA, Henderson SR, Maxwell A (2017) DNA topoisomerase I and DNA gyrase as targets for TB therapy. Drug Discovery Today 22(3):510\u2013518","journal-title":"Drug Discovery Today"},{"issue":"5","key":"12869_CR83","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/ddr.22063","volume":"84","author":"G Kumar","year":"2023","unstructured":"Kumar G, C A (2023) Natural products and their analogues acting against Mycobacterium tuberculosis: A recent update. Drug Dev Res 84(5):779\u2013804","journal-title":"Drug Dev Res"},{"key":"12869_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2011.12.029","volume":"49","author":"A Garc\u00eda","year":"2012","unstructured":"Garc\u00eda A, Bocanegra-Garc\u00eda V, Palma-Nicol\u00e1s JP, Rivera G (2012) Recent advances in antitubercular natural products. Eur J Med Chem 49:1\u201323","journal-title":"Eur J Med Chem"},{"issue":"3","key":"12869_CR85","doi-asserted-by":"publisher","first-page":"825","DOI":"10.14716\/ijtech.v16i3.5620","volume":"16","author":"R Arbianti","year":"2025","unstructured":"Arbianti R, Latifah LP, Sisila G, Utami TS, Hidayatullah IM, Riyadi FA, Muharam Y (2025) Molecular docking analysis of flavonoid from Strobilanthes crispus L. as potential inhibitors of Mycobacterium tuberculosis targeted proteins. Int J Technol 16(3):825\u2013834","journal-title":"Int J Technol"},{"issue":"10052","key":"12869_CR86","first-page":"1","volume":"13","author":"K Singh","year":"2024","unstructured":"Singh K, Jain D, Chaitanya MVNL, Kumar S (2024) A review of molecular investigations on traditional Chinese medicinal plant-based therapies in multidrug-resistant tuberculosis. Pharmacol Res 13(10052):1","journal-title":"Pharmacol Res"},{"issue":"1","key":"12869_CR87","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41598-020-57658-8","volume":"10","author":"A Pawar","year":"2020","unstructured":"Pawar A, Jha P, Chopra M, Chaudhry U, Saluja D (2020) Screening of natural compounds that targets glutamate racemase of Mycobacterium tuberculosis reveals the anti-tubercular potential of flavonoids. Sci Rep 10(1):949","journal-title":"Sci Rep"},{"issue":"10","key":"12869_CR88","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1099\/mic.0.2007\/009936-0","volume":"153","author":"AK Brown","year":"2007","unstructured":"Brown AK, Papaemmanouil A, Bhowruth V, Bhatt A, Dover LG, Besra GS (2007) Flavonoid inhibitors as novel antimycobacterial agents targeting Rv0636, a putative dehydratase enzyme involved in Mycobacterium tuberculosis fatty acid synthase II. Microbiology 153(10):3314\u20133322","journal-title":"Microbiology"},{"key":"12869_CR89","doi-asserted-by":"crossref","unstructured":"Appetecchia F, Biava M, Poce G (2022) Natural Flavonoid and Chalcone Scaffolds as Leads for Synthetic Antitubercular Agents. In: Carradori S (ed) Flavonoids and Phenolics. Bentham Science, pp 145\u2013172","DOI":"10.2174\/9789815079098122010008"},{"issue":"13","key":"12869_CR90","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.3390\/molecules24132449","volume":"24","author":"MH Mazlun","year":"2019","unstructured":"Mazlun MH, Sabran SF, Mohamed M, Abu Bakar MF, Abdullah Z (2019) Phenolic compounds as promising drug candidates in tuberculosis therapy. Molecules 24(13):2449","journal-title":"Molecules"},{"key":"12869_CR91","doi-asserted-by":"publisher","first-page":"116087","DOI":"10.1016\/j.biopha.2023.116087","volume":"171","author":"X Huang","year":"2024","unstructured":"Huang X, Lowrie DB, Fan XY, Hu Z (2024) Natural products in anti-tuberculosis host-directed therapy. Biomed Pharmacother 171:116087","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"12869_CR92","first-page":"56","volume":"1","author":"SS Sanap","year":"2025","unstructured":"Sanap SS, More PS, Thombre KR, Gupta KR (2025) Natural Flavonoids: Myricetin and Its Derivatives as Emerging Therapeutics, SAR and Molecular Target Analysis. Biopress J Ethnobotanical Innovations Herb Ther (BJEIHT) 1(1):56\u201367","journal-title":"Biopress J Ethnobotanical Innovations Herb Ther (BJEIHT)"},{"issue":"8","key":"12869_CR93","doi-asserted-by":"publisher","first-page":"E18715265361578","DOI":"10.2174\/0118715265361578250504110100","volume":"25","author":"K Kisimba","year":"2025","unstructured":"Kisimba K, Kasumbwe K, Odun-Ayo F, Faya M (2025) Flavonoids: Potential Novel Inhibitors of Mycobacterium tuberculosis. Infect Disorders-Drug Targets 25(8):E18715265361578","journal-title":"Infect Disorders-Drug Targets"},{"issue":"43","key":"12869_CR94","doi-asserted-by":"publisher","first-page":"10423","DOI":"10.1002\/chem.201701812","volume":"23","author":"SA Villaume","year":"2017","unstructured":"Villaume SA, Fu J, N\u2019Go I, Liang H, Lou H, Kremer L, Pan W, Vincent SP (2017) Natural and synthetic flavonoids as potent Mycobacterium tuberculosis UGM inhibitors. Chemistry\u2013A Eur J 23(43):10423\u201310429","journal-title":"Chemistry\u2013A Eur J"},{"issue":"5","key":"12869_CR95","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.ijantimicag.2005.09.002","volume":"26","author":"TT Cushnie","year":"2005","unstructured":"Cushnie TT, Lamb AJ (2005) Antimicrobial activity of flavonoids. Int J Antimicrob Agents 26(5):343\u2013356","journal-title":"Int J Antimicrob Agents"},{"issue":"19","key":"12869_CR96","doi-asserted-by":"publisher","first-page":"10634","DOI":"10.1039\/C8RA00636A","volume":"8","author":"NV Puranik","year":"2018","unstructured":"Puranik NV, Srivastava P, Swami S, Choudhari A, Sarkar D (2018) Molecular modeling studies and in vitro screening of dihydrorugosaflavonoid and its derivatives against Mycobacterium tuberculosis. RSC Adv 8(19):10634","journal-title":"RSC Adv"},{"issue":"16","key":"12869_CR97","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.3390\/molecules27165335","volume":"27","author":"AA Rabaan","year":"2022","unstructured":"Rabaan AA, Alhumaid S, Albayat H, Alsaeed M, Alofi FS, Al-Howaidi MH, Turkistani SA, Alhajri SM, Alahmed HE, Alzahrani AB, Mashraqi MM, Alwarthan S, Alhajri M, Alshahrani FS, Almuthree SA, Alsubki RA, Abuzaid AA, Alfaresi M, Fares A, M.A., Mutair AA (2022) Promising antimycobacterial activities of flavonoids against Mycobacterium sp. drug targets: a comprehensive review. Molecules 27(16):5335","journal-title":"Molecules"},{"issue":"1","key":"12869_CR98","doi-asserted-by":"publisher","first-page":"132","DOI":"10.2174\/0929867321666140916113443","volume":"22","author":"Y Xie","year":"2015","unstructured":"Xie Y, Yang W, Tang F, Chen X, Ren L (2015) Antibacterial activities of flavonoids: structure-activity relationship and mechanism. Curr Med Chem 22(1):132\u2013149","journal-title":"Curr Med Chem"},{"issue":"2","key":"12869_CR99","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1007\/s40203-024-00253-w","volume":"12","author":"A Haj Hasan","year":"2024","unstructured":"Haj Hasan A, Preet G, Astakala RV, Al-Adilah H, Oluwabusola ET, Ebel R, Jaspars M (2024) Antibacterial activity of natural flavones against bovine mastitis pathogens: in vitro, SAR analysis, and computational study. Silico Pharmacol 12(2):78","journal-title":"Silico Pharmacol"},{"key":"12869_CR100","doi-asserted-by":"crossref","unstructured":"Bollikolla HB, Anandam R, Chinnam S, Varala R, Khandapu BMK, Kapavarapu R, Syed KS, Dubasi N, Syed MA (2023) C-Dimethylated Flavones as Possible Potential Anti\u2010Tubercular and Anticancer Agents. Chem Biodivers, 20(4)","DOI":"10.1002\/cbdv.202201201"},{"issue":"5","key":"12869_CR101","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1590\/S0102-695X2011005000076","volume":"21","author":"A Castellar","year":"2011","unstructured":"Castellar A, Coelho TS, Silva PE, Ramos DF, Louren\u00e7o MCS, Lage CL, Juli\u00e3o LS, Barbosa YG, Leit\u00e3o SG (2011) The activity of flavones and oleanolic acid from Lippia lacunosa against susceptible and resistant Mycobacterium tuberculosis strains. Revista Brasileira de Farmacognosia 21(5):835\u2013840","journal-title":"Revista Brasileira de Farmacognosia"},{"key":"12869_CR102","doi-asserted-by":"crossref","unstructured":"Khare S, Dewangan RP, Kumar A (2022) Structure-activity relationship of flavonoids: Recent updates. In: Chaurasia P K, Bharati S L (ed) The chemistry inside spices & herbs: research and development. Bentham Science, pp 237\u2013259","DOI":"10.2174\/9789815039566122010011"},{"issue":"6","key":"12869_CR103","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.1007\/s00044-012-0268-7","volume":"22","author":"AK Yadav","year":"2013","unstructured":"Yadav AK, Thakur J, Prakash OM, Khan F, Saikia D, Gupta MM (2013) Screening of flavonoids for antitubercular activity and their structure\u2013activity relationships. Med Chem Res 22(6):2706\u20132716","journal-title":"Med Chem Res"},{"issue":"2","key":"12869_CR104","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1002\/ptr.7352","volume":"36","author":"SR Alizadeh","year":"2022","unstructured":"Alizadeh SR, Ebrahimzadeh MA (2022) O-Glycoside quercetin derivatives: Biological activities, mechanisms of action, and structure\u2013activity relationship for drug design, a review. Phytother Res 36(2):778\u2013807","journal-title":"Phytother Res"},{"key":"12869_CR105","doi-asserted-by":"crossref","unstructured":"Singh R, Pandey A, Pandey A (2025) In silico evaluation of flavonoids (apigenin, quercetin, and kaempferol) as potential inhibitors of LytB in multidrug-resistant Streptococcus pneumoniae. Lett Drug Des Discovery 22(11):1002","DOI":"10.1016\/j.lddd.2025.100224"},{"key":"12869_CR106","doi-asserted-by":"crossref","unstructured":"Jnawali, H. N., Jeon, D., Jeong, M. C., Lee, E., Jin, B., Ryoo, S., \u2026 Kim, Y. (2016).Antituberculosis activity of a naturally occurring flavonoid, isorhamnetin. Journal of natural products, 79(4), 961\u2013969.","DOI":"10.1021\/acs.jnatprod.5b01033"},{"key":"12869_CR107","doi-asserted-by":"crossref","unstructured":"Yusuf AR, Putra WE, Susanto H, Widiastuti D, Hidayatullah A (2025) Potential Drug Screening of Alpinia galanga (L.) Willd Bioactive Compound against Inhibitor Enoyl-Acyl Carrier Protein Reductase (INHA) Mycobacterium tuberculosis. ASM Sc J 20(2):1-9","DOI":"10.32802\/asmscj.2025.1763"},{"issue":"12","key":"12869_CR108","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.2174\/1568026622666220221110506","volume":"22","author":"Z Tan","year":"2022","unstructured":"Tan Z, Deng J, Ye Q, Zhang Z (2022) The antibacterial activity of natural-derived flavonoids. Curr Top Med Chem 22(12):1009\u20131019","journal-title":"Curr Top Med Chem"},{"issue":"1","key":"12869_CR109","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1089\/adt.2015.673","volume":"14","author":"SI Farah","year":"2016","unstructured":"Farah SI, Abdelrahman AA, North EJ, Chauhan H (2016) Opportunities and challenges for natural products as novel antituberculosis agents. Assay Drug Dev Technol 14(1):29\u201338","journal-title":"Assay Drug Dev Technol"},{"issue":"20","key":"12869_CR110","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2174\/1568026621666210705170510","volume":"21","author":"SS Swain","year":"2021","unstructured":"Swain SS, Hussain T, Pati S (2021) Drug-lead anti-tuberculosis phytochemicals: A systematic review. Curr Top Med Chem 21(20):1832\u20131868","journal-title":"Curr Top Med Chem"},{"key":"12869_CR111","doi-asserted-by":"crossref","unstructured":"Abdjul, D. B., Budiyanto, F., Wibowo, J. T., Murniasih, T., Rahmawati, S. I., Indriani,D. W., \u2026 Bayu, A. (2025). Unlocking potent anti-tuberculosis natural products through structure\u2013activity relationship analysis. Natural Products and Bioprospecting, 15(1), 44.","DOI":"10.1007\/s13659-025-00529-4"},{"key":"12869_CR112","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/B978-0-444-59530-0.00015-0","volume":"38","author":"S Veluthoor","year":"2012","unstructured":"Veluthoor S, Badi P, Mukharjee K, Mandal V (2012) Phytochemicals: in pursuit of antitubercular drugs. Stud Nat Prod Chem 38:417\u2013463","journal-title":"Stud Nat Prod Chem"},{"issue":"4","key":"12869_CR113","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3390\/pharmaceutics15041105","volume":"15","author":"ZJ Feng","year":"2023","unstructured":"Feng ZJ, Lai WF (2023) Chemical and biological properties of biochanin A and its pharmaceutical applications. Pharmaceutics 15(4):1105","journal-title":"Pharmaceutics"},{"issue":"3","key":"12869_CR114","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2174\/1573409919666230419094700","volume":"20","author":"MT Muhammed","year":"2024","unstructured":"Muhammed MT, Aki-Yalcin E (2024) Computational insight into the mechanism of action of DNA gyrase inhibitors; revealing a new mechanism. Curr Comput-Aided Drug Design 20(3):224\u2013235","journal-title":"Curr Comput-Aided Drug Design"},{"key":"12869_CR115","doi-asserted-by":"crossref","unstructured":"Y\u0131ld\u0131r\u0131m K (2025) In Silico Evaluation of the Antituberculosis Potential of the Interaction Between Genistein and TLR2. J Balkan Sci Technol 4(1):9\u201316","DOI":"10.55848\/jbst.2025.07"},{"issue":"5","key":"12869_CR116","doi-asserted-by":"publisher","first-page":"223","DOI":"10.3390\/antibiotics9050223","volume":"9","author":"NJ Sadgrove","year":"2020","unstructured":"Sadgrove NJ, Oliveira TB, Khumalo GP, van Vuuren SF, van Wyk BE (2020) Antimicrobial isoflavones and derivatives from Erythrina (Fabaceae): structure activity perspective (Sar & Qsar) on experimental and mined values against Staphylococcus aureus. Antibiotics 9(5):223","journal-title":"Antibiotics"},{"key":"12869_CR117","unstructured":"AlMutairi MM, Magadmi RM, Shaik RA, AlKreathy HM (2025) Biochanin A: A Comprehensive Overview of its Pharmacological Properties and Therapeutic Potential. Bahrain Med Bull, 47(2):2230"},{"key":"12869_CR118","doi-asserted-by":"publisher","first-page":"622629","DOI":"10.3389\/fmicb.2020.622629","volume":"11","author":"LA Pollo","year":"2021","unstructured":"Pollo LA, Martin EF, Machado VR, Cantillon D, Wildner LM, Bazzo ML, Waddell SA, Bisvatti MW, Sandjo LP (2021) Search for antimicrobial activity among fifty-two natural and synthetic compounds identifies anthraquinone and polyacetylene classes that inhibit Mycobacterium tuberculosis. Front Microbiol 11:622629","journal-title":"Front Microbiol"},{"key":"12869_CR119","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmech.2011.12.029","volume":"49","author":"A Garc\u00eda","year":"2012","unstructured":"Garc\u00eda A, Bocanegra-Garc\u00eda V, Palma-Nicol\u00e1s JP, Rivera G (2012) Recent advances in antitubercular natural products. Eur J Med Chem 49:1\u201323","journal-title":"Eur J Med Chem"},{"issue":"18","key":"12869_CR120","doi-asserted-by":"publisher","first-page":"16228","DOI":"10.1021\/acsomega.3c00684","volume":"8","author":"VR Jagatap","year":"2023","unstructured":"Jagatap VR, Ahmad I, Sriram D, Kumari J, Adu DK, Ike BW, Ghai M, Ansari SA, Ansari IA, Wetchoua POM, Karpoormath R, Patel H (2023) Isoflavonoid and furanochromone natural products as potential DNA gyrase inhibitors: computational, spectral, and antimycobacterial studies. ACS omega 8(18):16228","journal-title":"ACS omega"},{"key":"12869_CR121","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jep.2017.05.019","volume":"206","author":"EW Coronado-Aceves","year":"2017","unstructured":"Coronado-Aceves EW, Gigliarelli G, Garibay-Escobar A, Zepeda RER, Curini M, Cervantes JL, Espitia-Pinz\u00f3n CI, Superchi S, Vergura S, Marcotullio MC, Marcotullio MC (2017) New Isoflavonoids from the extract of Rhynchosia precatoria (Humb. & Bonpl. ex Willd.) DC. and their antimycobacterial activity. J Ethnopharmacol 206:92\u2013100","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"12869_CR122","first-page":"4032105","volume":"2018","author":"S Hamza Sherif","year":"2018","unstructured":"Hamza Sherif S, Gebreyohannes B (2018) Synthesis, characterization, and antioxidant activities of genistein, biochanin A, and their analogues. J Chem 2018(1):4032105","journal-title":"J Chem"},{"key":"12869_CR123","doi-asserted-by":"publisher","first-page":"107","DOI":"10.12688\/f1000research.126059.3","volume":"12","author":"PV Anuranjana","year":"2023","unstructured":"Anuranjana PV, Beegum F, George KT, Viswanatha GL, Nayak PG, Kanwal A, Kishore A, Shenoy RR, Nandakumar K (2023) Mechanisms behind the pharmacological application of biochanin-A: a review. F1000Research 12:107","journal-title":"F1000Research"},{"issue":"14","key":"12869_CR124","doi-asserted-by":"publisher","first-page":"e202500249","DOI":"10.1002\/cmdc.202500249","volume":"20","author":"SD Calixto","year":"2025","unstructured":"Calixto SD, Falc\u00e3o JS, Antunes SS, Araujo MH, Cunha AL, Martins DR, Nascimento SMR, Sim\u00e3o TLBV, Lasunskaia EB, Romeiro NC, Costa PRR, Muzitano MF, Caleffi GS (2025) Intracellular and Extracellular Efficacy of Homoisoflavone Derivatives Against Mycobacterium Tuberculosis: Progress Toward Novel Antitubercular Agents. ChemMedChem 20(14):e202500249","journal-title":"ChemMedChem"},{"key":"12869_CR125","doi-asserted-by":"crossref","unstructured":"Husain A, Ahmad A, Mkhalid IAI, Mishra R, Rashid M (2013) Synthesis and antimicrobial activity of bischalcone derivatives. Medicinal Chemistry Research, 22(4), 1578\u20131586.] [Kozlowski, D., Trouillas, P., Calliste, C., Marsal, P., Lazzaroni, R., & Duroux, J. L. (2007). Density functional theory study of the conformationlectronic, and antioxidant properties of natural chalcones. The Journal of Physical Chemistry A, 111(6), 1138\u20131145","DOI":"10.1021\/jp066496+"},{"key":"12869_CR126","doi-asserted-by":"crossref","unstructured":"Nowakowska Z (2007) A review of anti-infective and anti-inflammatory chalcones. European journal of medicinal chemistry, 42(2), 125\u2013137.] [Cushnie, T. T., & Lamb, A. J. (2011). Recent advances in understanding the antibacterial properties of flavonoids. International journal of antimicrobial agents, 38(2), 99\u2013107","DOI":"10.1016\/j.ejmech.2006.09.019"},{"issue":"10","key":"12869_CR127","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3390\/ph15101250","volume":"15","author":"G Rajendran","year":"2022","unstructured":"Rajendran G, Bhanu D, Aruchamy B, Ramani P, Pandurangan N, Bobba KN, Oh EJ, Chung HY, Gangadaran P, Ahn BC (2022) Chalcone: A promising bioactive scaffold in medicinal chemistry. Pharmaceuticals 15(10):1250","journal-title":"Pharmaceuticals"},{"key":"12869_CR128","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.ejmech.2017.05.026","volume":"137","author":"MN Gomes","year":"2017","unstructured":"Gomes MN, Braga RC, Grzelak EM, Neves BJ, Muratov E, Ma R, Klein LL, Cho S, Oliveira GR, Franzblau SG, Andrade CH (2017) QSAR-driven design, synthesis and discovery of potent chalcone derivatives with antitubercular activity. Eur J Med Chem 137:126\u2013138","journal-title":"Eur J Med Chem"},{"issue":"6","key":"12869_CR129","doi-asserted-by":"publisher","first-page":"e0265068","DOI":"10.1371\/journal.pone.0265068","volume":"17","author":"SB Lagu","year":"2022","unstructured":"Lagu SB, Yejella RP, Nissankararao S, Bhandare RR, Golla VS, Lokesh S, B. V., Shaik AB (2022) Antitubercular activity assessment of fluorinated chalcones, 2-aminopyridine-3-carbonitrile and 2-amino-4H-pyran-3-carbonitrile derivatives: in vitro, molecular docking and in-silico drug likeliness studies. PLoS ONE 17(6):e0265068","journal-title":"PLoS ONE"},{"issue":"22","key":"12869_CR130","doi-asserted-by":"publisher","first-page":"19194","DOI":"10.1021\/acsomega.3c01035","volume":"8","author":"K Mezgebe","year":"2023","unstructured":"Mezgebe K, Melaku Y, Mulugeta E (2023) Synthesis and pharmacological activities of chalcone and its derivatives bearing N-heterocyclic scaffolds: a review. ACS omega 8(22):19194\u201319211","journal-title":"ACS omega"},{"issue":"5","key":"12869_CR131","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/13543776.2019.1613374","volume":"29","author":"D Kar Mahapatra","year":"2019","unstructured":"Kar Mahapatra D, Asati V, Bharti SK (2019) An updated patent review of therapeutic applications of chalcone derivatives (2014-present). Expert Opin Ther Pat 29(5):385\u2013406","journal-title":"Expert Opin Ther Pat"},{"key":"12869_CR132","doi-asserted-by":"publisher","first-page":"1453426","DOI":"10.3389\/fphar.2024.1453426","volume":"15","author":"M Liu","year":"2024","unstructured":"Liu M, Du Y, Gao D (2024) Licochalcone A: a review of its pharmacology activities and molecular mechanisms. Front Pharmacol 15:1453426","journal-title":"Front Pharmacol"},{"issue":"2","key":"12869_CR133","doi-asserted-by":"publisher","first-page":"103581","DOI":"10.1016\/j.arabjc.2021.103581","volume":"15","author":"S Ammaji","year":"2022","unstructured":"Ammaji S, Masthanamma S, Bhandare RR, Annadurai S, Shaik AB (2022) Antitubercular and antioxidant activities of hydroxy and chloro substituted chalcone analogues: Synthesis, biological and computational studies. Arab J Chem 15(2):103581","journal-title":"Arab J Chem"},{"issue":"24","key":"12869_CR134","doi-asserted-by":"publisher","first-page":"15165","DOI":"10.1080\/07391102.2023.2227711","volume":"41","author":"D LS","year":"2023","unstructured":"LS D, MK, K., Thamilselvan G (2023) Design, synthesis and anti-Tb evaluation of chalcone derivatives as novel inhibitors of InhA. J Biomol Struct Dynamics 41(24):15165\u201315176","journal-title":"J Biomol Struct Dynamics"},{"issue":"19","key":"12869_CR135","doi-asserted-by":"publisher","first-page":"4539","DOI":"10.3390\/molecules29194539","volume":"29","author":"K Aziafor","year":"2024","unstructured":"Aziafor K, Ruparelia K, Moulds B, Zloh M, Parish T, Brucoli F (2024) Design and Synthesis of Pyridyl and 2-Hydroxyphenyl Chalcones with Antitubercular Activity. Molecules 29(19):4539","journal-title":"Molecules"},{"key":"12869_CR136","volume-title":"New Insights into the Origin and Therapeutic Implications of Benzopyran","author":"MV Singh","year":"2023","unstructured":"Singh MV, Tiwari AK (2023) New Insights into the Origin and Therapeutic Implications of Benzopyran. A Review, and their Derivatives"},{"issue":"20","key":"12869_CR137","doi-asserted-by":"publisher","first-page":"8398","DOI":"10.1021\/jm500853v","volume":"57","author":"L Feng","year":"2014","unstructured":"Feng L, Maddox MM, Alam MZ, Tsutsumi LS, Narula G, Bruhn DF, Wu X, Sandhaus S, Lee RB, Simmons CJ, Tse-Dinh YC, Hurdle JG, Sun D (2014) Synthesis, structure\u2013activity relationship studies, and antibacterial evaluation of 4-chromanones and chalcones, as well as olympicin A and derivatives. J Med Chem 57(20):8398\u20138420","journal-title":"J Med Chem"},{"key":"12869_CR138","doi-asserted-by":"publisher","first-page":"1713869","DOI":"10.3389\/fmed.2025.1713869","volume":"12","author":"B Yu","year":"2025","unstructured":"Yu B, Zhang J, Zhu M, Li Z, Ren L, Zhang F, Liu C, Zhang L (2025) Flavonoids: a natural remedy in the prevention and management of diverse diseases. Front Med 12:1713869","journal-title":"Front Med"},{"issue":"9","key":"12869_CR139","doi-asserted-by":"publisher","first-page":"859","DOI":"10.2174\/1570180818666210421140331","volume":"18","author":"S Mahanta","year":"2021","unstructured":"Mahanta S, Gogoi B, Chetia P, Tanti B, Handique PJ (2021) Identification of active phytochemical from traditional herbal knowledge-base targeting pantothenate synthetase for anti-tuberculosis therapy. Lett Drug Des Discovery 18(9):859\u2013871","journal-title":"Lett Drug Des Discovery"},{"issue":"4","key":"12869_CR140","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/molecules27041149","volume":"27","author":"NF Shamsudin","year":"2022","unstructured":"Shamsudin NF, Ahmed QU, Mahmood S, Ali Shah SA, Khatib A, Mukhtar S, Alsharif MA, Parveen H, Zakaria ZA (2022) Antibacterial effects of flavonoids and their structure-activity relationship study: A comparative interpretation. Molecules 27(4):1149","journal-title":"Molecules"},{"issue":"14","key":"12869_CR141","doi-asserted-by":"publisher","first-page":"4491","DOI":"10.3390\/molecules27144491","volume":"27","author":"A Sychrov\u00e1","year":"2022","unstructured":"Sychrov\u00e1 A, \u0160kovranov\u00e1 G, \u010culenov\u00e1 M, Bittner Fialov\u00e1 S (2022) Prenylated flavonoids in topical infections and wound healing. Molecules 27(14):4491","journal-title":"Molecules"},{"issue":"4","key":"12869_CR142","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1007\/s43450-025-00659-3","volume":"35","author":"M Lei","year":"2025","unstructured":"Lei M, Zhao Z, Li X, Qiao H, Zhou W (2025) Bioactivity and Structure\u2013Activity relationship of Epigallocatechin and Epigallocatechin-3-Gallate derivatives. Revista Brasileira de Farmacognosia 35(4):641\u2013665","journal-title":"Revista Brasileira de Farmacognosia"},{"issue":"2","key":"12869_CR143","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3390\/antibiotics15020141","volume":"15","author":"N Masikantsi","year":"2026","unstructured":"Masikantsi N, Mbau R, Tukur N, Masoko P, Mashabela G (2026) Discovery of Novel Derivatives of Catechin Gallate with Antimycobacterial Activity from Kirkia wilmsii Engl. Extracts Antibiotics 15(2):141","journal-title":"Extracts Antibiotics"},{"issue":"7","key":"12869_CR144","doi-asserted-by":"publisher","first-page":"4126","DOI":"10.1021\/acsbiomaterials.0c00823","volume":"6","author":"A Sharma","year":"2020","unstructured":"Sharma A, Vaghasiya K, Ray E, Gupta P, Gupta UD, Singh AK, Verma RK (2020) Targeted pulmonary delivery of the green tea polyphenol epigallocatechin gallate controls the growth of mycobacterium tuberculosis by enhancing the autophagy and suppressing bacterial burden. ACS Biomaterials Sci Eng 6(7):4126\u20134140","journal-title":"ACS Biomaterials Sci Eng"},{"key":"12869_CR145","doi-asserted-by":"publisher","first-page":"118642","DOI":"10.1016\/j.ijpharm.2019.118642","volume":"570","author":"J Zhao","year":"2019","unstructured":"Zhao J, Yang J, Xie Y (2019) Improvement strategies for the oral bioavailability of poorly water-soluble flavonoids: An overview. Int J Pharm 570:118642","journal-title":"Int J Pharm"},{"issue":"28","key":"12869_CR146","doi-asserted-by":"publisher","first-page":"7730","DOI":"10.1080\/10408398.2021.1917508","volume":"62","author":"L Chen","year":"2022","unstructured":"Chen L, Cao H, Huang Q, Xiao J, Teng H (2022) Absorption, metabolism and bioavailability of flavonoids: A review. Crit Rev Food Sci Nutr 62(28):7730\u20137742","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"1","key":"12869_CR147","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1080\/10717544.2021.1927244","volume":"28","author":"H Li","year":"2021","unstructured":"Li H, Li M, Fu J, Ao H, Wang W, Wang X (2021) Enhancement of oral bioavailability of quercetin by metabolic inhibitory nanosuspensions compared to conventional nanosuspensions. Drug Delivery 28(1):1226\u20131236","journal-title":"Drug Delivery"},{"issue":"9","key":"12869_CR148","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1080\/10717544.2016.1223218","volume":"23","author":"S Zhang","year":"2016","unstructured":"Zhang S, Wang J, Pan J (2016) Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Drug Delivery 23(9):3696\u20133703","journal-title":"Drug Delivery"},{"key":"12869_CR149","unstructured":"Joshi SP, Kulkarni RR, Shurpali KD, Sarkar S, Sarkar D (2013) Anti-tubercular compounds, WO2013021258A1 (to Council of Scientific and Industrial Research CSIR), 14 Feb 2013"},{"key":"12869_CR150","unstructured":"Lin YM (2009) Anti-mycobacterium compositions and methods of preparing and using same. U.S. Patent US20040147597A1. 24 Feb 2009"},{"key":"12869_CR151","unstructured":"Krawczyk-\u0141ebek A, Kostrzewa-Sus\u0142ow K, Dymarska M, Janeczko T (2020) 6-Hydroxymethyl-3\u2019-O-\u03b2-D-(4\u2019-O-methylglucopyranosyl)-flavanone and method of preparation of 6-hydroxymethyl-3\u2019-O-\u03b2-D-(4\u2019-O-methylglucopyranosyl)-flavanone, Poland Patent PL242335B1 13 feb 2023"},{"key":"12869_CR152","unstructured":"Krawczyk-\u0141ebek A, Kostrzewa-Sus\u0142ow E, Dymarska M, Janeczko T (2021) 2\u2019-Methyl-4\u2019-O-\u03b2-D-(4\u2019\u2019-O-methylglucopyranosyl)-flavone and method for preparing 2\u2019-methyl-4\u2019-O-\u03b2-D-(4\u2019\u2019-O-methylglucopyranosyl)-flavone, Poland Patent Application No. PL248132B1"},{"key":"12869_CR153","unstructured":"Krawczyk-\u0141ebek A, Kostrzewa-Sus\u0142ow E, Dymarska M, Janeczko T (2026) 2\u2019-Hydroxy-5\u2019-chloro-3-O-\u03b2-D-(4\u2019\u2019-O-methylglucopyranosyl)-chalcone and method for preparing 2\u2019-hydroxy-5\u2019-chloro-3-O-\u03b2-D-(4\u2019\u2019-O-methylglucopyranosyl)-chalcone, Poland Patent Application No. PL249206B1"},{"key":"12869_CR154","unstructured":"Krawczyk-\u0141ebek A, Kostrzewa-Sus\u0142ow E, Dymarska M, Janeczko T (2026) 2-Chloro-2\u2019,5-dihydroxy-3\u2019-O-\u03b2-D-(4\u2019\u2019-O-methylglucopyranosyl)-dihydrochalcone and method for producing 2-chloro-2\u2019,5-dihydroxy-3\u2019-O-\u03b2-D-(4\u2019\u2019-O-methylglucopyranosyl)-dihydrochalcone, Poland Patent Application No. PL249025B1"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12869-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12869-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:05:14Z","timestamp":1791673514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12869-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,10]]},"references-count":153,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12869"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12869-6","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,10]]},"assertion":[{"value":"18 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that we have no conflicts of interest.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Ethics declaration","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1694"}}